Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanie L Groenland

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
The Right Dose: From Phase I to Clinical PracticeStefanie L Groenland, Mark J Ratain, Lisa S Chen, et al.
BMC Cancer|December 5, 2018
Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levelsStefanie L Groenland, Daniela Katz, Alwin D R Huitema, et al.
European Journal of Clinical Pharmacology|June 9, 2019
Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicineStefanie L Groenland, Ron H J Mathijssen, Jos H Beijnen, et al.
BMC Nephrology|December 31, 2017
Relation between duration of the prodromal phase and renal damage in ANCA-associated vasculitisEline Houben, Stefanie L Groenland, Joost W van der Heijden, et al.
International Journal of Pharmaceutics|April 23, 2018
Solubility and bioavailability improvement of pazopanib hydrochlorideMaikel Herbrink, Stefanie L Groenland, Alwin D R Huitema, et al.
European Journal of Clinical Pharmacology|May 21, 2020
Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdoseJeroen Roosendaal, Stefanie L Groenland, Hilde Rosing, et al.
Clinical Pharmacokinetics|June 5, 2018
Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in OncologyStefanie L Groenland, Merel van Nuland, Remy B Verheijen, et al.
Clinical Pharmacokinetics|October 8, 2020
Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and AbemaciclibStefanie L Groenland, Alejandra Martínez-Chávez, Marloes G J van Dongen, et al.
British Journal of Cancer|February 11, 2025
Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patientsMaud B A van der Kleij, Marinda Meertens, Stefanie L Groenland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2021
Precision Dosing of Targeted Therapies Is Ready for Prime TimeStefanie L Groenland, Remy B Verheijen, Markus Joerger, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
The Right Dose: From Phase I to Clinical PracticeStefanie L Groenland, Mark J Ratain, Lisa S Chen, et al.
BMC Cancer|December 5, 2018
Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levelsStefanie L Groenland, Daniela Katz, Alwin D R Huitema, et al.
European Journal of Clinical Pharmacology|June 9, 2019
Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicineStefanie L Groenland, Ron H J Mathijssen, Jos H Beijnen, et al.
BMC Nephrology|December 31, 2017
Relation between duration of the prodromal phase and renal damage in ANCA-associated vasculitisEline Houben, Stefanie L Groenland, Joost W van der Heijden, et al.
International Journal of Pharmaceutics|April 23, 2018
Solubility and bioavailability improvement of pazopanib hydrochlorideMaikel Herbrink, Stefanie L Groenland, Alwin D R Huitema, et al.
European Journal of Clinical Pharmacology|May 21, 2020
Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdoseJeroen Roosendaal, Stefanie L Groenland, Hilde Rosing, et al.
Clinical Pharmacokinetics|June 5, 2018
Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in OncologyStefanie L Groenland, Merel van Nuland, Remy B Verheijen, et al.
Clinical Pharmacokinetics|October 8, 2020
Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and AbemaciclibStefanie L Groenland, Alejandra Martínez-Chávez, Marloes G J van Dongen, et al.
British Journal of Cancer|February 11, 2025
Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patientsMaud B A van der Kleij, Marinda Meertens, Stefanie L Groenland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2021
Precision Dosing of Targeted Therapies Is Ready for Prime TimeStefanie L Groenland, Remy B Verheijen, Markus Joerger, et al.
Pageof 3